Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$3.61 - $9.87 $577,600 - $1.58 Million
-160,000 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$3.99 - $7.82 $638,400 - $1.25 Million
160,000 New
160,000 $1.18 Million

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $434M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track Prem Watsa's Portfolio

Track Prem Watsa Portfolio

Follow Prem Watsa (Fairfax Financial Holdings LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfax Financial Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fairfax Financial Holdings LTD and Prem Watsa with notifications on news.